Benanserin
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Benanserin, also known as benzyl antiserotonin (BAS), by its developmental code name MC-4788 or Sq-4788, and by its chemical name 1-benzyl-2-methyl-5-methoxytryptamine, is a serotonin receptor antagonist and described tranquilizer of the tryptamine and 5-methoxytryptamine families.[2][1][3][4] It is the derivative of 5-methoxytryptamine with a benzyl group at the 1 position and a methyl group at the 2 position.[2][3] The drug is said to be active in humans at a dose of 10 to 35 mg orally or intravenously.[1] In contrast to certain other serotonin receptor antagonists like chlorpromazine, benanserin does not antagonize the subjective effects of the serotonergic psychedelic LSD.[4] It was first described in the scientific literature by at least 1955 and was one of the first serotonin antagonists.[2][5]
| Clinical data | |
|---|---|
| Other names | Benanserine; MC-4788; Sq-4788; Benzyl antiserotonin; Benzylantiserotonin; BAS; Serotonin benzyl analogue; Wooley's antiserotonin; 1-Benzyl-2-methyl-5-methoxytryptamine |
| Routes of administration | Oral, intravenous injection[1] |
| Drug class | Serotonin receptor antagonist; Tranquilizer |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H22N2O |
| Molar mass | 294.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |